Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;99:389-397
Published online before print July 27, 2006, doi: 10.1161/01.RES.0000237920.70451.ad
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
99/4/389    most recent
01.RES.0000237920.70451.adv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singaraja, R. R.
Right arrow Articles by Hayden, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singaraja, R. R.
Right arrow Articles by Hayden, M. R.
Related Collections
Right arrow Cell biology/structural biology
Right arrow Lipid and lipoprotein metabolism
(Circulation Research. 2006;99:389.)
© 2006 American Heart Association, Inc.


Molecular Medicine

Specific Mutations in ABCA1 Have Discrete Effects on ABCA1 Function and Lipid Phenotypes Both In Vivo and In Vitro

Roshni R. Singaraja, Henk Visscher, Erick R. James, Angeliki Chroni, Jonathan M. Coutinho, Liam R. Brunham, Martin H. Kang, Vassilis I. Zannis, Giovanna Chimini, Michael R. Hayden

From the Center for Molecular Medicine and Therapeutics (R.R.S., H.V., E.R.J., J.M.C., L.R.B., M.H.K., M.R.H.), University of British Columbia and Child and Family Research Institute, Vancouver, British Columbia, Canada; the Whitaker Cardiovascular Institute (A.C., V.I.Z.), Boston University School of Medicine, Boston, Mass; and Institut Nationale de la Santé et de la Recherche Médicale/Centre Nationale de Recherche Scientifique et Universite de La Mediterranee (G.C.), Marseille, France.

Correspondence to Dr. Michael R. Hayden, Center for Molecular Medicine and Therapeutics, 950 W 28th Ave, Vancouver, British Columbia, V5Z 4H4, Canada. E-mail mrh{at}cmmt.ubc.ca

Mutations in ATP-binding cassette transporter A1 (ABCA1) cause Tangier disease and familial hypoalphalipoproteinemia, resulting in low to absent plasma high-density lipoprotein cholesterol levels. However, wide variations in clinical lipid phenotypes are observed in patients with mutations in ABCA1. We hypothesized that the various lipid phenotypes would be the direct result of discrete and differing effects of the mutations on ABCA1 function. To determine whether there is a correlation between the mutations and the resulting phenotypes, we generated in vitro 15 missense mutations that have been described in patients with Tangier disease and familial hypoalphalipoproteinemia. Using localization of ABCA1, its ability to induce cell surface binding of apolipoprotein A-I, and its ability to elicit efflux of cholesterol and phospholipids to apolipoprotein A-I we determined that the phenotypes of patients correlate with the severity and nature of defects in ABCA1 function.


Key Words: ABCA1 • basic research • cell culture • cholesterol homeostasis • HDL cholesterol • mutation • tissue culture




This article has been cited by other articles:


Home page
Circ. Res.Home page
J. F. Oram and A. M. Vaughan
ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease
Circ. Res., November 10, 2006; 99(10): 1031 - 1043.
[Abstract] [Full Text] [PDF]